Indometacin Bristol Laboratories

Indometacin, the active ingredient in Indometacin Bristol Laboratories, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is employed to relieve inflammation, pain and fever associated with rheumatic disorders and acute gout attacks in adult patients.

GNH USA supplies Indometacin Bristol Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare providers worldwide, ensuring quality, regulatory compliance and reliable delivery across global markets through a robust logistics network and support.

Indometacin is an NSAID that reduces inflammation by inhibiting cyclooxygenase enzymes, and it is indicated for several musculoskeletal and inflammatory conditions.

- Rheumatoid arthritis: reduces joint inflammation and pain in affected patients. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Ankylosing spondylitis: helps control spinal inflammation and mobility limitation. - Gout flares: provides rapid relief of acute gouty arthritis pain. - Bursitis and tendinitis: diminishes swelling and improves function. - Mild to moderate pain and fever: offers symptomatic relief when other agents are insufficient.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, abdominal pain. - Headache or dizziness. - Skin rash or pruritus. - Elevated liver enzymes. - Mild renal function changes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe renal impairment or failure. - Hepatotoxicity with jaundice. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome. - Anaphylactic or severe hypersensitivity reactions. - Cardiovascular events including hypertension or thrombotic events.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly.

- Assess renal function: check serum creatinine and adjust if impairment exists. - Monitor hepatic enzymes: watch for signs of liver injury during treatment. - Evaluate gastrointestinal risk: consider prophylaxis in patients with ulcer history. - Use caution in cardiovascular disease: monitor blood pressure and signs of thrombosis. - Avoid in known hypersensitivity to indometacin or other NSAIDs. - Store at room temperature: keep in the original container, protect from moisture and light.

Indometacin can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Lithium: elevated lithium serum concentrations. - Methotrexate: heightened methotrexate toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: potential reduction in renal function. - Diuretics: increased risk of nephrotoxicity and electrolyte imbalance. - Corticosteroids: additive risk of gastrointestinal ulceration.